Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)
Clinical trial NCT04439123 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04439123
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-31
- Primary completion
- 2019-11-08
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.